Skip to content
10-Q

Quarterly Report

ALSERES PHARMACEUTICALS INC /DE

0001193125-14-211193

← back to feed
Filed
May 23, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 30, 2014 30.64M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$385.45K
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$700.6K
Short Term Investments Q1 2014 · Mar 31, 2014 $175.66K
Short Term Investments Q1 2014 · Dec 31, 2013 $196.65K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $93.51K
Cash And Equivalents Q1 2014 · Dec 31, 2013 $113.96K
Cash And Equivalents Q1 2014 · Mar 31, 2013 $92.86K
Cash And Equivalents Q1 2014 · Dec 31, 2012 $16.53K
Stockholders Equity Q1 2014 · Mar 31, 2014 −$11.02M
Stockholders Equity Q1 2014 · Dec 31, 2013 −$10.66M
Current Liabilities Q1 2014 · Mar 31, 2014 $1.69M
Current Liabilities Q1 2014 · Dec 31, 2013 $1.65M
Total Liabilities Q1 2014 · Mar 31, 2014 $10.99M
Total Liabilities Q1 2014 · Dec 31, 2013 $10.65M
Current Assets Q1 2014 · Mar 31, 2014 $304.53K
Current Assets Q1 2014 · Dec 31, 2013 $324.64K
Total Assets Q1 2014 · Mar 31, 2014 $364.43K
Total Assets Q1 2014 · Dec 31, 2013 $385.47K
Sga Expense Q1 2014 · Mar 31, 2014 $348.16K
Sga Expense Q1 2014 · Mar 31, 2013 $439.68K
Net Income Q1 2014 · Mar 31, 2014 −$332.01K
Net Income Q1 2014 · Mar 31, 2013 −$297.86K
Operating Income Q1 2014 · Mar 31, 2014 −$330.65K
Operating Income Q1 2014 · Mar 31, 2013 −$16.22K
Revenue Q1 2014 · Mar 31, 2014 $18.43K
Revenue Q1 2014 · Mar 31, 2013 $18.43K